Graninger, Monika <br/><br/>
Angiotensin receptor blockade decreases markers of vascular inflammation.  [electronic resource] 

 -  Journal of cardiovascular pharmacology  Sep 2004 
 - 335-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0160-2446 
<br/><br/><label>Standard No.: </label>10.1097/01.fjc.0000137160.76616.cc  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin Receptor Antagonists<br/>Blood Pressure--drug effects<br/>Cholesterol--blood<br/>Double-Blind Method<br/>E-Selectin--blood<br/>Enalapril--administration & dosage<br/>Enzyme-Linked Immunosorbent Assay--methods<br/>Female<br/>Flow Cytometry--methods<br/>Humans<br/>Hypercholesterolemia--diagnosis<br/>Inflammation--diagnosis<br/>Intercellular Adhesion Molecule-1--blood<br/>Leukocytes--drug effects<br/>Losartan--administration & dosage<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Receptors, Angiotensin--therapeutic use<br/>Vascular Cell Adhesion Molecule-1--blood<br/>Vascular Diseases--diagnosis